Aires Research Timeline: 1992 to 2025 – airestech

Este sitio web tiene ciertas restriucciones de navegación. Le recomendamos utilizar buscadores como: Edge, Chrome, Safari o Firefox.

FREE Bored Panda childrens book with Orders $250+ Limited Time Only!

Aires Research Timeline: 1992 to 2025

Aires Research Timeline: 1992 to 2025

The evidence base for Aires technology has been built across 33 years of continuous research — beginning before smartphones existed, accelerating through the Wi-Fi era, and extending through the arrival of 5G. This timeline documents the research arc.

Foundation Era (1992–2001)

1992 — Founding and Initial Research

The Aires Human Genome Research Foundation is established in St. Petersburg, Russia. Inventor Igor Serov begins developing the concept of coherent EMF transformation via self-affine fractal geometry. The theoretical foundation is laid in what will become the Universal Space Theory (UST).

1996–2000 — First EMF Measurements

Early RF range resonator experiments characterize intrinsic frequency behavior across 1–40 GHz. Key finding: the resonator self-assembles its output frequency structure independent of input — a signature of the fractal cavity mechanism.

2000 — Russian Ministry of Health Protocol Approval

The Russian Ministry of Health approves an official clinical trial protocol for the Aires Matrix Applicator. This represents the first government recognition of Aires technology for medical use. Protocol documentation ›

2000 — Army Medical Academy Clinical Trial

St. Petersburg Army Medical Academy conducts clinical trials of the Aires Matrix Applicator in 21 subjects with psychoemotional stress. EEG, HRV, cognitive and neuromotor tests all show significant improvement. Read the study ›

2001–2002 — Bekhterev Institute EEG Research

V.M. Bekhterev National Medical Research Center conducts EEG research on Aires Optical Fractal Matrix Filters in 54 patients with anxious asthenic syndrome — the largest single EEG study in the corpus. All subjects show EEG normalization. Read the study ›

Expansion Era (2002–2010)

2002 — Zenin Water Conductivity Study

Dr. Stanislav Zenin (Ministry of Health, Russia) documents that radiotelephone EMF measurably alters water electrical conductivity. The Aires Electromagnetic Abnormalities Neutralizer provides complete compensation. First empirical evidence of the device's physical effect on a measurable system. Read the study ›

2003 — Rybina & Alexandrov: EEG "Electromagnetic Storm" Discovery

Larisa Rybina and Boris Alexandrov (Pavlov Institute) document that mobile phone use creates what they term an "electromagnetic storm" in EEG brain patterns — significant disruption of normal brainwave coherence. Aires Shield reduces the disruption. A foundational finding replicated in all subsequent EEG studies. Read the study ›

2003 — Comparative EEG Study (7 Devices)

Rybina compares Aires NEMA against 6 competing protective devices. Aires outperforms all alternatives on all EEG measures. Read the study ›

2005 — Tarlykov Erythrocyte Study (ITMO)

Prof. Vladimir Tarlykov at ITMO University demonstrates that the Aires Fractal Resonator improves erythrocyte deformability in blood from multiple myeloma patients. Read the study ›

2006 — Korotkov GDV Research

Dr. Konstantin Korotkov (inventor of GDV/Bio-Well technology) conducts preliminary assessment of Aires device effect on physical sensor and mobile phone radiation fields.

Systematic Validation Era (2013–2018)

2013 — Datova HRV Study

Svetlana Datova (Tyumen State University) conducts 13-subject placebo-controlled HRV study. Aires Defender significantly improves heart rate variability and autonomic regulation. Read the study ›

2013 — Zenin Water Structure Protection Study

Follow-up water study confirming Aires Microprocessor (Shield, Defender, AquaCluster) all protect aqueous environment structure from EMF-induced changes. Placebo-controlled design. Read the study ›

2014 — Sysoev & Serov EEG Study (GSM-900)

Prof. Sysoev (Military Medical Academy) and Serov conduct 11-subject EEG study. Aires Shield eliminates mobile phone-induced theta/alpha elevation on the phone-side brain hemisphere. Read the study ›

2015 — Havas (Trent University) Cardiovascular Studies

Dr. Magda Havas at Trent University, Canada, publishes two independent case studies showing Aires Defender Infinity improves cardiovascular response during radiofrequency radiation exposure. First international (non-Russian) research institution to study Aires. Placebo-controlled design. Read the studies ›

2016 — VGTU Phase I: Spectrum Analyzer Measurement

Prof. Jukna and Dr. Jasaitis at Vilnius Gediminas Technical University (Lithuania) conduct Phase I independent testing using a spectrum analyzer. Result: 27% average reduction in electric field strength across 0.9–2.5 GHz. Read the study ›

2016 — IFRAN Stage 1: Chromosome Aberration Discovery

Dyuzhikova and colleagues at Pavlov Institute document that Wi-Fi router exposure causes 4.5× increase in chromosome aberrations in rat bone marrow. Aires Defender reduces aberrations 4-fold. This finding launches the 5-stage longitudinal IFRAN research program. Read Stage 1 ›

2016 — Kopyltsov et al. Distributed Computing Publication

First peer-reviewed computational paper on EMF interaction with structured surfaces by Kopyltsov, Korshunov, Lukyanov & Serov. Confirmed fractal self-similarity of field response. Read the study ›

2017 — IFRAN Stages 2 & 3: DNA and Memory Effects

Stage 2 confirms DNA damage across multiple rat genetic lines. Stage 3 documents Wi-Fi-induced memory impairment and its restoration by Aires resonators. Stages 2 & 3 ›

2017–2018 — VGTU Phases II & III: Interference Mechanism Confirmed

Follow-up VGTU testing confirms interference mechanism (20% field amplitude reduction) and demonstrates fractal antenna threshold excitation at 2W input. Three phases complete. Read Phases II & III ›

2018 — ITMS Peer-Reviewed Publication (VGTU + ITMO)

Joint publication by Jukna/Jasaitis (VGTU) and Lukyanov/Kopyltsov (ITMO) in ITMS 2018 proceedings. Circular fractal structure measurably dampens GHz-frequency electromagnetic waves. First peer-reviewed joint publication with international co-authors. Read the ITMS paper ›

2018 — IFRAN Stage 4: Magnetic Field Effects

Reduced magnetic field disrupts behavior in HT and LT rat lines; Aires Defender Pro normalizes effects in both. Stage 4 ›

2018 — Dyuzhikova Chromosome Aberration Paper Published (Journal)

Peer-reviewed journal article published in Electromagnetic Waves and Electronic Systems confirming Wi-Fi chromosome aberration effects and Aires protection. Read the paper ›

Advanced Validation Era (2019–2025)

2019 — Patent Filed (WO2021/064446)

WIPO global patent application filed covering the method for transforming technogenic EMF into coherent radiation via self-affine fractal resonator. Filing date establishes priority claim.

2019 — IFRAN Stage 5: Locomotion, Bees, hsp70 Gene

Stage 5 covers two sub-programs: (a) locomotion effects in LT rats normalized by Aires Defender Pro; (b) Wi-Fi router suppresses hsp70 stress-response gene expression in honey bee brain; Aires Defender Pro restores it to control levels. The bee hsp70 finding is particularly significant — it documents a gene expression effect that survives in a non-mammalian system. Stage 5 ›

2020 — Rybina EEG Study (15 Subjects)

Rybina conducts rigorous 15-subject EEG study documenting mobile phone EMF disruption and Aires Resonator restoration of normal patterns. Read the study ›

2020 — Kuznetsova ECG/HRV Study (15 Subjects)

Aires Shield Pro reduces regulatory stress index by 2× during mobile phone exposure in 15-subject study. Read the study ›

2020 — Rybina Lifetune Personal Protection EEG

First study specifically on the Lifetune Personal Protection device in the 40–60 year old demographic. Alpha power increase documented during 15-minute application. Read the study ›

2022 — Springer Publication (ICICT 2022)

Lukyanov, Kopyltsov & Serov publish peer-reviewed computer simulation in Springer Lecture Notes in Networks and Systems — ICICT 2022 proceedings. Confirms the self-affine pattern semiconductor wafer generates coherent electromagnetic radiation. First Springer publication for any EMF consumer device company. Read the Springer paper ›

2025 — US Patent Granted (US12239835B2)

US Patent US12239835B2 granted March 4, 2025. Covers coherent EMF transformation via self-affine fractal resonator across 2.4 GHz through 28 GHz (Wi-Fi through 5G mmWave). Expires December 13, 2040. Patent examination provides independent legal validation of novelty and utility. Patent documentation ›

2025 — Pavlov Institute: First Wi-Fi 6 and First Genotype-Dependent Response

Most recent study. Pavlov Institute tests Lifetune Zone Max against Wi-Fi 6 router (the latest router technology) on rats. Key findings: (1) Wi-Fi 6 router measurably alters blood parameters; (2) Lifetune Zone Max normalizes them; (3) for the first time in this research program, genotype-dependent variation in EMF response is documented — rats of different genetic backgrounds show different sensitivities and different magnitudes of protection. This finding may explain individual differences in electromagnetic sensitivity in humans. Read the 2025 study ›

2026 — ICICT 2026 Thermal Imaging Confirmation

Lukyanov & Makarov use thermal imaging to physically confirm that the Aires resonator self-affine surface behaves as a near-black-body electromagnetic cavity — providing direct physical measurement evidence of the resonator mechanism, independent of computational models. Published at Springer ICICT 2026. Read the thermal imaging study ›

What This Timeline Demonstrates

The research arc is not a collection of isolated studies — it is a sustained, cumulative scientific program with five clear properties:

  1. Chronological continuity (33 years): Research did not start when the company needed marketing. It started at the founding and has continued without interruption.
  2. Methodological escalation: Early descriptive studies gave way to placebo-controlled designs, multi-stage longitudinal programs, and peer-reviewed publications.
  3. Geographic expansion: Research that began exclusively in Russia expanded to Canada (Trent, 2015), Lithuania (VGTU, 2016–2018), and the US (UFC Performance Institute).
  4. Convergent validation: Physical mechanism (simulation, thermal imaging, spectrum analysis) and biological outcomes (EEG, HRV, genetics, blood) converge on the same conclusion independently.
  5. Current-technology validation: The 2025 IFRAN study and 2026 ICICT publication are the most recent additions — the research program continues to match evolving wireless technology (Wi-Fi 6, 5G mmWave).

Research overview › | Full research library › | Researcher profiles ›